Ahmed Mohamed Hasanin
Cairo, 11432, Egypt
NCT Number: NCT03844984
The aim of the work is to investigate the effect of using lidocaine in combination with low dose ketamine in induction of anesthesia for septic shock patients compared to normal dose of ketamine.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 3
Cairo, 11432, Egypt
Most of the drugs used for induction of anesthesia negatively impact patient hemodynamics. Thus, induction of anesthesia in shocked patients might result in deleterious hypotension. Patients with severe sepsis and septic shock frequently need surgical interventions. The best protocol for induction of anesthesia in septic shock patients is lacking.
Ketamine is an agent used for induction of anesthesia with known positive cardiovascular effects. However, these positive effects were reported in individuals with intact sympathetic nervous system. Invitro studies showed that ketamine direct action on the cardiac muscles is negative. Thus, it had been recommended that ketamine should be used with caution in hemodynamically vulnerable patients till further randomized controlled trials are present.
Lidocaine is a drug with multiple local and systemic uses. Having local anesthetic properties, lidocaine was proposed to have an anesthetic sparing effect. Lidocaine was previously reported to enhance the hypnotic effect of thiopentone, propofol, and midazolam during induction of anesthesia. Lidocaine showed a sparing effect for volatile as well as intravenous requirements for maintenance of anesthesia; thus, we hypothesize that its use as an adjuvant during induction of anesthesia in septic shock patient could provide a sparing effect for ketamine and minimize its negative circulatory sequelae.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This group will receive induction of anesthesia using Ketamine 1 mg/Kg.
Other names: Ketamine hydrochloride
This group will receive midazolam 0.05 mg/Kg
Other names: dormicum
This group will receive normal saline 10 mL
This group will receive induction of anesthesia using Ketamine 0.5 mg/Kg.
Other names: Ketamine hydrochloride
This group will receive lidocaince 1 mg/Kg diluted in 10 mL normal saline.
Other names: Lidocaine hydrochloride
Time frame: 10 minutes after induction of general anesthesia
Mean arterial blood pressure measured in mmHg
Time frame: 10 minutes after induction of general anesthesia
Number of heart beats per minute
Time frame: 5 minutes after induction of general anesthesia
The number of patients who suffer from decreased mean arterial pressure by 10% from the baseline reading during the first 5 minutes after induction of anesthesia
Time frame: 10 minutes after induction of general anesthesia
Volume of blood pumped by the heart in one minute measured in liters per minute
Time frame: 10 minutes after induction of general anesthesia
The total dose of norepinephrine measured in micrograms
Time frame: 10 minutes after induction of general anesthesia
Systolic arterial blood pressure measured in mmHg
Cairo University
Other
Lidocaine-Ketamine Versus Ketamine for Induction of Anesthesia in Septic Shock Patients: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06363149
Blood Coagulation Disorders, Critical Illness
Lucknow, Uttar Pradesh, India
View Trial DetailsNCT07695337
Infections, Inflammation
Banhā, Qalyubia Governorate, Egypt
View Trial DetailsNCT05824767
Infections, Inflammation
Albuquerque, New Mexico, United States
View Trial DetailsNCT07313670
Infections, Inflammation
Karachi, Sindh, Pakistan
View Trial Details